Analysis of the Effects of Perioperative Nursing Intervention for Patients with Cerebrovascular Intervention

Objective:To explore the clinical application effects of perioperative nursing intervention in the treatment of patients with cerebrovascular intervention.Methods:176 patients with cerebrovascular intervention in our hospital from October 2018 to March 2020 were selected and randomly divided into 2 groups,with 88 cases in the control group and 88 cases in the observation group.Comparative analysis of blood pressure and incidence of complications was performed.Results:During the operation,the systolic blood pressure of the observation group increased by(11.85±1.66)mmHg,and the diastolic blood pressure was(4.63±0.45)mmHg.The control group patients'systolic blood pressure increased by(22.12±1.98)mmHg and the diastolic blood pressure was(8.36±3.69)mmHg,the two results were significantly different.The blood pressure of the patients in the control group fluctuated more;and the incidence of complications in the observation group is lower than that of the control group.The observation group's incidence of hematoma,low back discomfort,dysuria,and insomnia and dreaminess was 2.27%,2.27%,1.14%,0%,respectively,with total incidence of 5.68%;in the control group,the incidence of hematoma,low back discomfort,dysuria,insomnia and dreaminess were 6.81%,5.68%,3.41%,4.55%respectively,total incidence being 20.45%.The difference between observation group and control group is obvious.Conclusion:Through perioperative nursing intervention,the recovery speed of patients can be improved,and the incidence of postoperative complications can be reduced.The mental state of the patient before the operation was adjusted,the emotions were calmed,the patient's compliance was improved,and the patient's resistive emotions were reduced.At the same time,if patients can get good nursing care after surgery,the probability of postoperative complications is reduced,so that patients have better results in surgery,and its clinical application is worthy of promotion.

Correlation between serum fructosamine and hyperglycemia in patients with acute cerebrovascular disease

BACKGROUND: Diabetes mellitus is one of the risk factors in patients with acute cerebral disease, and always leads to stroke or get it worse. There is often a high level of blood glucose in those patients with diabetes mellitus and cerebral disease, but it is hard to distinguish from both kinds of hyperglycemia. Serum fructosamine is said to be correlated with blood glucose. OBJECTIVE: To explore the relationship between serum fructosamine and blood glucose in patients with acute cerebrovascular disease. DESIGN: A case-controlled study. SETTINGS: Department of Clinical Laboratory, Health Department for Cadres and Department of Neurology of Affiliated Hospital, Qingdao University Medical College. PARTICIPANTS: Forty-eight inpatients and outpatients with cerebrovascular diseases were selected from the Department of Neurology, Affiliated Hospital of Qingdao University Medical College from December 2004 to April 2005. All the patients were confirmed with CT and MRI. There were 25 patients with diabetes mellitus secondary cerebrovascular diseases, who met the diagnostic standards of diabetes mellitus set by WHO, including 12 males and 13 females with an average of (60±8) years old, the course of diabetes mellitus ranged from 1 to 21 years.. The other 23 patients had no diabetes mellitus (without diabetes mellitus group), including 14 males and 9 females with an average of (62±6) years old. Meanwhile, another 50 healthy physical examinees in the hospital were selected as control group, including 26 males and 24 females with the average age of (62±5) years old. Informed content was obtained from all the participants. METHODS: Venous blood was drawn from all the participants, and content of blood glucose was assayed by means of glucose oxidase, and the concentration of serum fructosamine was determined by nitroblue tetrazolium colorimetric method. Comparison between groups was performed by the analysis of variance and q test, and the correlation was tested by linear regression analysis. MAIN OUTCOME MEASURES: ① Comparison of blood glucose and serum fructosamine among the groups; ② Correlation between serum fructosamine and blood glucose in patients with diabetes mellitus secondary cerebrovascular diseases and those without diabetes mellitus. RESULTS: All the 48 patients with cerebrovascular disease and 50 healthy subjects were involved in the analysis of results. ① Contents of blood glucose and serum fructosamine: There were obvious differences in the contents of blood glucose and serum fructosamine among the diabetes mellitus group, without diabetes mellitus group and control group (F =577.7, 115.1, P < 0. 01). The content of serum fructosamine in the diabetes mellitus group [(4.25±1.35) mmol/ L] was obviously higher than those in the control group and without diabetes mellitus group [(1.65±0.27), (1.96±0.25) mmol/ L, q =1.47, 1.30, P < 0.01], whereas there was no significant difference between the without diabetes mellitus group and control group (P > 0.05). The content of blood glucose was obviously higher in the patients with and without diabetes mellitus groups [(15.80±2.13), (9.50 ±1.78) mmol/L] than in the control group [(4.56 ±0.77) mmol/L, q =1.86, 2.46, P < 0.01], also markedly higher in the with diabetes mellitus group than in the without diabetes mellitus group (q =1.42, P < 0.01). ② Results of correlation analysis: The content of serum fructosamine was positively correlated with the level of fasting blood glucose in the patients with diabetes mellitus secondary cerebrovascular diseases (r = 0.603, P < 0.01). But there was no relationship between serum fructosamine and fasting blood glucose in the patients without diabetes mellitus (r =0.357, P > 0.05). CONCLUSION: The contents of blood glucose and serum fructosamine were obviously different among the diabetes mellitus group, without diabetes mellitus group and control group. There are closer relations between serum fructosamine and blood glucose in patients with diabetes mellitus secondary cerebral disorders, which are not observed in the patients without diabetes mellitus. Fructosamine is significant in differentiating the reasons for the increased blood glucose in patients with acute cerebrovascular disease.